Yimeng Lu

Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del

Jennifer L. Taylor‐Cousar, À. Munck, Edward F. McKone et al. · New England Journal of Medicine · 2017 · 778 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +10

Efficacy and safety of NVA237 <i>versus</i> placebo and tiotropium in patients with COPD: the GLOW2 study

Edward Kerwin, Jacques Hébert, Nicola Gallagher et al. · European Respiratory Journal · 2012 · 209 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Efficacy and safety of once-daily NVA237 in patients with moderate-to-severe COPD: the GLOW1 trial

Anthony D’Urzo, Gary T. Ferguson, J.A. van Noord et al. · Respiratory Research · 2011 · 177 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Safety and Efficacy of CTX001 in Patients with Transfusion-Dependent β-Thalassemia and Sickle Cell Disease: Early Results from the Climb THAL-111 and Climb SCD-121 Studies of Autologous CRISPR-CAS9-Modified CD34+ Hematopoietic Stem and Progenitor Cells

Haydar Frangoul, Yael Bobruff, Maria Domenica Cappellini et al. · Blood · 2020 · 51 citations

Life Sciences, Genetics, Hematology +16

Transport and metabolic profiling studies of amentoflavone in Caco-2 cells by UHPLC-ESI-MS/MS and UHPLC-ESI-Q-TOF-MS/MS

Baolin Wang, Yimeng Lu, Rong Wang et al. · Journal of Pharmaceutical and Biomedical Analysis · 2020 · 26 citations

Life Sciences, Biochemistry, Pharmacology +12